You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Optimized lactoferrin for treatment of intracerebral hemorrhage

    SBC: Pharmareview Corporation            Topic: NINDS

    DESCRIPTION provided by applicant Intracerebral hemorrhage ICH is a major public health problem with highest mortality rate of all stroke subtypes and long term disability Since there are no available FDA approved therapies for ICH it is of enormous importance to establish effective treatment for this medical condition Following ICH the deposited blood is damaging initially via compression ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Ovarian cancer using novel nanoparticle formulations

    SBC: KIROMIC BIOPHARMA INC            Topic: 102

    DESCRIPTION provided by applicant Ovarian cancer is the fifth most leading cause of cancer related deaths in women in the US It has been observed that the cancer relapses within relatively short periods of time even after the surgery and chemotherapy Therefore immunotherapeutic strategies may serve as an alternative to control the recurrence or progression of ovarian cancer Oral vaccines ar ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Automated Manufacture of Damage Detecting, Self-Healing Composite Cryogenic Pressure Vessels

    SBC: AURORA FLIGHT SCIENCES CORPORATION            Topic: T1002

    During Phase I, Aurora Flight Sciences and the University of Massachusetts Lowell propose to demonstrate the feasibility of enhancing a commercially available out-of-autoclave (OOA) carbon prepreg material system (e.g. IM7/5320) via embedded structural health monitoring (SHM) and self-healing capabilities, which can be manufactured by an automated fiber placement (AFP) machine. This proposed "sma ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  4. Novel Metal Organic Framework Synthesis for Spacecraft Oxygen Capture

    SBC: BUSEK CO., INC.            Topic: T602

    Busek and University of Utah propose to develop novel metal organic framework (MOF) material to efficiently capture oxygen in spacecraft cabin environment. The proposed novel MOF is postulated to be capable of separating oxygen from ambient air with high efficiency, and at the same time, be stable to moisture and resistant to decomposition. In Phase I, our team shall synthesize the proposed MOF an ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  5. Heat Harvesting by Artificial Muscles

    SBC: LYNNTECH INC.            Topic: T301

    NASA emphasizes the need to implement energy harvesting in its future mission activities. By harvesting energy from the ambient surroundings, there is less dependence on a primary power supply (e.g., combustion engines, fuel cells, batteries, solar cells, etc.). Overall power consumption is thereby reduced, equipment weight goes down and logistical supply needs are simplified. Future NASA mission ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  6. In-Situ EBCs for High Performance Composite Propulsion Components

    SBC: PHYSICAL SCIENCES INC.            Topic: T1202

    Silicon Carbide based ceramic matrix composites (CMCs) offer the potential to fundamentally change the design and manufacture of aeronautical and space propulsion systems to significantly increase performance and fuel efficiency over current metal-based designs. Physical Sciences Inc. (PSI) and our team members at the University of California Santa Barbara (UCSB) will develop, design and fabricat ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  7. Low Cost Flexible Graphene-Based Digital Beam Forming Phased-Array Antennas

    SBC: OMEGA OPTICS, INC.            Topic: T501

    Communication technologies support all NASA space missions, among which autonomous communication technologies are extremely beneficial to future missions. Communication technologies will expand mankind's understanding of planet earth and the universe. As the needs to gather more data, even more advanced antenna technologies will be essential to deliver orders of magnitude more data. Low cost high ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  8. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. New heterocyclic inhibitors of filoviruses

    SBC: MICROBIOTIX, INC.            Topic: H

    DESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. New small molecule inhibitors of arenaviruses

    SBC: MICROBIOTIX, INC.            Topic: R

    DESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government